Various cookies are used on our website: We use technically necessary cookies for the purpose of enabling functions such as login or a shopping cart. We use optional cookies for marketing and optimization purposes, in particular to place relevant and interesting ads for you on Meta's platforms (Facebook, Instagram). You can refuse optional cookies. More information on data collection and processing can be found in our privacy policy.
Luigi Canullo raduated cum laude in Dentistry and Dental Prosthesis at the University of Rome “La Sapienza” in 1994. PhD at the University of Bonn (Germany). National and international speaker on surgical and prosthetic aspects of implant dentistry. He is author of more than 100 articles published on international journals on topics related to implantology. Active member of the Italian Academy for Osseointegration (IAO) and the European Academy of Osseointegration (EAO). Visiting Professor at the University of Bern (Switzerland), Assistant Professor at the University of Genova (Italy). Reviewer for the most important journals in implant dentistry. His professional office is in Rome, limiting his private practice at surgery and implant supported prosthetic rehabilitation.
Prima edizione 2011 Book Copertina rigida, formato 21x28cm, 176 pages, 500 illustrations Language: Italian Category: Implantology ISBN 978-88-7492-160-7 QP Italy
Events
Bone, Biomaterials & Beyond Academy
Guided Bone Regeneration Symposium7. Mar 2025 — 8. Mar 2025Hilton Porto Gaia, Vila Nova de Gaia, Portugal
Speakers: Imad About, Luigi Canullo, Rok Gašperšič, Gerd Körner, Christopher Köttgen, Iva Milinkovic, Ulf Nannmark, Patrick Palacci, Adriano Piattelli, Patrick R. Schmidlin, Claudio Stacchi, Tiziano Testori, Hannes Wachtel, Michael Weinländer
Bone, Biomaterials & Beyond Academy
European Prosthodontic Debates 2023
14. Sep 2023 — 16. Sep 2023Radisson Blu Hotel Lietuva, Vilnius, Lithuania
Speakers: Rolandas Andrijauskas, Adomas Auskalnis, Kazuyoshi Baba, Tord Berglundh, Lawrence E. Brecht, Luigi Canullo, Farronato Davide , Luca De Stavola, Vincent Fehmer, Marco Ferrari, German O. Gallucci, Ieva Gendviliene, Simonas Grybauskas, Sascha Hein, Reinhilde Jacobs, Matthias Kern, Tomas Linkevičius, Diego Lops, Daniele Manfredini, Francesco Mangano, Magda Mensi, Eitan Mijiritsky, Suresh Nayar, Sam Omar, George Papavasiliou, Guillermo Pradíes, Algirdas Puišys, Aušra Ramanauskaitė, Daniele Rondoni, Dmitri Ruzanov, Irena Sailer, Frank Schwarz, Nicola Scotti, Tristan Staas, Eglė Vindašiūtė-Narbutė, Ulrich Wegmann, Lukasz Zadrozny, Ausra Znamenskaite-Levickiene
European Prosthodontic Association
29th EAO annual scientific meeting
Uniting Nations through Innovations29. Sep 2022 — 1. Oct 2022Palexpo, Le Grand-Saconnex, Switzerland
Speakers: Thabo Beeler, Nitzan Bichacho, Rino Burkhardt, Luigi Canullo, Matteo Chiapasco, Luca De Stavola, Mirela Feraru, Alfonso L. Gil, Klaus Gotfredsen DDS, PhD, Markus Gross, Ueli Grunder, Christoph Hämmerle, Björn Klinge, Ivo Krejci, Sebastian Kühl, Niklaus P. Lang, Sonia Leziy, Daniele Manfredini, Konrad H. Meyenberg, Francesco Mintrone, Ricardo Mitrani, Sven Mühlemann, José M. Navarro, Florian Probst, Pablo Ramírez, Christoph Ramseier, Mario roccuzzo, Fidel Ruggia, Mariano Sanz, Rubens Spin-Neto, Dennis P. Tarnow, Daniel Thoma, Istvan Urban, Hans-Peter Weber
European Association for Osseintegration (EAO)
The 14th International Symposium on Periodontics and Restorative Dentistry (ISPRD)
9. Jun 2022 — 12. Jun 2022Boston Marriott Copley Place, Boston, MA, United States of America
Speakers: Tara Aghaloo, Edward P. Allen, Evanthia Anadioti, Wael Att, Vinay Bhide, Markus B. Blatz, Scotty Bolding, Lorenzo Breschi, Jeff Brucia, Daniel Buser, Luigi Canullo, Daniele Cardaropoli, Stephen J. Chu, Donald Clem, Christian Coachman, Lyndon F. Cooper, Daniel Cullum, Lee Culp, José Carlos Martins da Rosa, Sergio de Paoli, Marco Degidi, Nicholas Dello Russo, Serge Dibart, Joseph P. Fiorellini, Mauro Fradeani, Stuart J. Froum, David Garber, Maria L. Geisinger, William Giannobile, Luca Gobbato, Ueli Grunder, Galip Gürel, Chad Gwaltney, Christoph Hämmerle, Robert A. Horowitz, Marc Hürzeler, David Kim, Gregg Kinzer, Christopher Köttgen, Ina Köttgen, Purnima S. Kumar, Burton Langer, Lydia Legg, Pascal Magne, Kenneth A. Malament, Jay Malmquist, George Mandelaris, Pamela K. McClain, Michael K. McGuire, Mauro Merli, Konrad H. Meyenberg, Craig M. Misch, Julie A. Mitchell, Marc L. Nevins, Myron Nevins, Michael G. Newman, Miguel A. Ortiz, Jacinthe M. Paquette, Stefano Parma-Benfenati, Michael A. Pikos, Giulio Rasperini, Pamela S. Ray, Christopher R. Richardson, Isabella Rocchietta, Marisa Roncati, Marco Ronda, Paul S. Rosen, Maria Emanuel Ryan, Irena Sailer, Maurice Salama, David M. Sarver, Takeshi Sasaki, Todd Scheyer, Massimo Simion, Michael Sonick, Sergio Spinato, Dennis P. Tarnow, Lorenzo Tavelli, Douglas A. Terry, Tiziano Testori, Carlo Tinti, Istvan Urban, Hom-Lay Wang, Robert Winter, Giovanni Zucchelli
Quintessence Publishing Co., Inc. USA
This author's journal articles
The International Journal of Oral & Maxillofacial Implants, Pre-Print
DOI: 10.11607/jomi.1143424. Jun 2025,Pages 1-24, Language: EnglishMenini, Maria / Canullo, Luigi / Pesce, Paolo / Bixio, Francesca / Bagnasco, Francesco / Del Fabbro, Massimo
Background: Implant rehabilitation has become one of the primary treatment options for both partial and total edentulism in contemporary dentistry. In the posterior maxilla, a challeng frequently arises from insufficient available bone volume; to overcome this limitation, sinus floor elevation (SFE) procedures are often necessary. Two main techniques are employed for this purpose: the lateral window approach and the transcrestal one. Purpose: to evaluate patient-reported outcome measures related to maxillary sinus augmentation and alternative options for the rehabilitation of atrophic posterior maxilla. Study Selection: An electronic search was conducted on PubMed, Scopus and Cochrane CENTRAL up to January 31st, 2025 to identify randomized and non-randomized comparative clinical studies involving at least one group treated with maxillary SFE, with a minimum of 5 patients per group, in which PROMs were assessed. The focused question was: In patients requiring rehabilitation of atrophic posterior maxilla, is there a protocol superior to others among SFE using lateral or transcrestal approach with or without grafting, and implant placement without augmentation, in terms of patient-reported outcome measures? Pairwise meta-analysis was undertaken to estimate the overall effect when at least two studies with similar treatment comparisons, reporting the same outcome, were found. The primary outcome was postoperative pain, measured using the VAS scale in the first seven days after surgery. Secondary outcomes were any other PROMs like postoperative symptoms or standard satisfaction questionnaires. Results: The electronic search initially identified 104 articles. After deduplication, 56 articles were screened, and 12 studies (12 RCTs and 1 non-RCT) were finally included. Ten studies were judged at moderate risk of bias and one RCT at high risk. The non-RCT study was judged at moderate risk of bias. Meta-analysis could be performed only for the proportion of patients reporting pain at 1, 3 and 7 days postoperatively. The graftless approach resulted in less pain at 3- and 7-days post-op compared to SFE with graft. Transcrestal SFE also showed less post-op discomfort than lateral SFE. Conclusions: The results indicated that patients may experience reduced discomfort and inflammation when graftless procedures and transcrestal approaches are used. Overall, there is a paucity of evidence regarding the assessment of PROMs in the rehabilitation of atrophic posterior maxilla.
Keywords: Bone graft, Bone substitute, Sinus lift
Purpose: To compare bone substitutes composed of glycated collagen with synthetic micro-sized (1 to 10 μm) hydroxyapatite (OB) vs non–cross-linked collagen matrix with large-particle (250 to 1,000 μm) bovine-derived hydroxyapatite (BOC). Materials and Methods: The P1 to P4 premolars were bilaterally extracted from the mandibles of 19 Beagle dogs. After 21 days, osteotomies were created in each dog that received OB or BOC and were covered with a collagen membrane or were left untreated. The animals were randomly divided into three groups based on sacrifice time (4, 12, or 24 weeks). The right and left hemimandibles were trimmed to facilitate imaging and histology, and all tissues were placed in 10% neutral-buffered formalin. Microcomputed tomography (MicroCT 40 Scanner, Scanco) was used to analyze bone sections. Bone volume, residual material volume, and bone mineral density were determined for each treatment site (OB and BOC) based on a volume of interest that encompassed the original defect. Additionally, blinded histopathologic assessment (based on the ISO 10993-6 scoring system) and histomorphometry were performed on sections ground to < 100 μm thick and stained with Stevenel’s blue. Results: No clinical side effects were noted. No statistical differences were observed for OB vs BOC regarding the mineral volume percentage. Compared to OB, BOC had significantly higher mean mineralization densities at 12 weeks (P < .01), but this difference did not extend to 24 weeks. For residual grafting material, bone maturation, alveolar ridge restoration, and inflammatory response, OB showed a residual amount of bone graft and no statistical differences compared to BOC. Conclusion: Both OB and BOC represent valid treatment options for critically sized bone defects. Both bone fillers outperformed the sham-operated, ungrafted (empty) control, demonstrating statistically improved bone growth and ridge restoration.
Keywords: bone grafting, collagen membrane, ridge augmentation, collagen scaffold
Purpose: To compare glycated multilayered membranes (OV) to a commercially available thin-layer membrane (OP) in a lateral ridge augmentation model in dogs.
Materials and Methods: This was designed as a three-arm study, where one negative control (empty defect) was compared to two test arms: alveolar bone defects grafted with a mixture of 90% deproteinized bovine bone mineral and 10% porcine collagen, then covered with either a thick- (OV) or thin-layered (OP) membrane. Animals were randomly divided into three groups corresponding to the final sacrifice times of 4 weeks, 12 weeks, and 24 weeks. Sections underwent microCT, histology, histopathology, and histomorphometry.
Results: No statistical differences were observed for OV compared to OP regarding the percentage of mineral volume and mean mineral density, amount of bone maturation, percentage of bone graft and membrane remaining in the grafted area, alveolar ridge width measurements, membrane mineralization, or ossification. Test groups presented significantly higher values compared to the empty control for all the endpoints.
Conclusions: Within its limitations, this in vivo study highlighted that multilayered thick glycated membranes can serve as effective occlusive barriers for up to 6 months.
Keywords: bone grafting, collagen membrane, ridge augmentation
Purpose: To monitor the early bone reaction in a canine model to a conventional sandblasted and dual acid-etched implant surface (ABT), a nanostructured hydrophilic surface (Nano), a dry salt–bioactivated ultra-hydrophilic surface (Hydro), and a bioactivated nanosurface obtained from the addition of dry salts to the Nano surface (Nano-Active).
Materials and Methods: ABT, Nano, Hydro, and Nano-Active implants were placed in 12 dogs. A randomized split-mouth design was adopted. One implant of each type was placed in the mandible 3 months after tooth extraction in healed sites at the first molar region bilaterally. In the same session, the third and fourth premolars were extracted bilaterally and one implant of each type was immediately placed into the extraction socket. The dogs were euthanized at 14 and 28 days following surgery, and the peri-implant bone reaction was assessed histologically using Stevenel’s blue and alizarin red in nondecalcified sections.
Results: The postoperative healing was uneventful. The 14-day histologic analysis reported nonsignificant results in terms of difference between the groups, while significant results were found 28 days after surgery. In fact, a significantly higher rate of new bone around the implant was reported in the Nano-Active compared to the Nano groups (51.0% ± 10.2% vs 36.0% ± 10.2%) and Hydro compared to the Nano groups (47.3% ± 10.7% vs 36.0% ± 10.2%).
Conclusion: The results obtained indicate that new bone formed after 4 weeks demonstrated a tendency for dry salt– treated bioactivated surfaces to improve bone deposition in the interface in the early stages of healing; however, due to the limited number of dogs, the results failed to show a statistical significance. A study with a significantly larger group of animals should be performed in order to challenge the assumption that ultra-hydrophilic–surface implants might show higher bone-implant contact in immediate postextraction replacement.
Keywords: bioactivated implant surface, histology, histomorphometric, nanosurface, salt-bioactivated surface, surface
The International Journal of Prosthodontics, 4/2022
DOI: 10.11607/ijp.7426Pages 380-386, Language: EnglishCanullo, Luigi / Hjerppe, Jenni / Menini, Maria / Bagnasco, Francesco / Petazzi, Guido Maria / Pesce, Paolo
Purpose: To retrospectively evaluate the survival rate and technical and biologic complications of feather-edge zirconia and metal-ceramic implant restorations cemented on conical titanium abutments.
Materials and methods: Patients rehabilitated with implant-supported single crowns or fixed dental prostheses (FDPs) were divided into four groups: ZR-TL = tissue-level implant with a convergent collar and zirconia restoration; ZR-BL = bone-level implant and zirconia restoration; MC-TL = tissue-level implant with a convergent collar and metal-ceramic restoration; MC-BL = bone-level implant and metal-ceramic restoration. All of the restorations were cemented onto conical titanium abutments and had feather-edge margins, following the biologically oriented preparation technique (BOPT). Crown-level survival rates, technical and biologic complications, and bone resorption were registered. Chi-square test was performed to analyze all evaluated parameters among the groups. Nonparametric Mann-Whitney test was performed to analyze changes in bone level.
Results: A total of 85 patients (133 implants, 66 single crowns, and 28 FDPs) were included in the present study with a mean follow-up time of 4.98 years. The overall survival rate was 98.2% for zirconia and 97.5% for metal-ceramic restorations at the crown level. No significant differences were found between the zirconia (ZR-BL and ZR-TL) and the metal-ceramic (MC-BL and MC-TL) groups for technical complications (P > .05). Bone resorption was 0.33 (0.37) mm in MC-TL; 0.61 (0.52) mm in MC-BL; 0.39 (0.51) mm in ZR-TL; and 0.77 (0.64) mm in ZR-BL, showing significantly greater bone loss in bone-level implants (P = .011).
Conclusion: Zirconia implant restorations with feather-edge margins seem to be a viable alternative in cases of both tissue-level and bone-level implants.
Purpose: After tooth extraction, a modeling and remodeling phase of bone and soft tissues occurs. It has been fully demonstrated that bone resorption as high as 50% can take place regarding ridge width and a variable amount concerning ridge height, making it difficult to perform implant surgery.
Materials and methods: Active members of the Italian Academy of Osseointegration (IAO) participated in this Consensus Conference, and three systematic reviews were conducted before the meeting to provide guidelines on alveolar ridge preservation procedures. The systematic reviews covered the following topics: (1) What material best preserves the dimensions of the ridge horizontally and vertically?; (2) what material favors the formation of the highest quantity of new bone?; (3) which technique would best seal the socket?; and (4) what effect does alveolar ridge preservation have on soft tissues?
Results: The main conclusions reached by the assembly were that alveolar ridge preservation is advisable after dental extraction, particularly in esthetic areas, in proximity of anatomical structures (ie, maxillary sinus, inferior alveolar nerve, and mental foramen), whenever the treatment plan requires delayed placement, and whenever patients ask to postpone implant insertion for various reasons. Socket debridement is advised before the use of a "regenerative material," and xenograft is considered the gold standard material to maintain ridge dimensions. Another indication is antibiotic therapy, which is recommended in the case of alveolar ridge preservation (amoxicillin 2 g 1 hour before the intervention and 1 g every 12 hours for 6 days). A membrane or autologous soft tissue should be used to seal the socket and protect the regenerative material, and the indicated reentry time (implant insertion) is 4 to 6 months.
Conclusion: This Consensus Conference agreed that the adoption of alveolar ridge preservation can effectively prevent physiologic bone loss, especially in esthetic areas. It is recommended to cover the xenograft material with a membrane or autologous soft tissue, and antibiotic therapy is advisable.
Keywords: antibiotics, bone regeneration, dental implants, postextraction site, surgery
Purpose: Bone graft materials and soft tissue allografts are widely used in clinical practice to counteract physiologic postextraction site tridimensional shrinkage. The aim of this study was to test if plasma of argon treatment could have a bioactivation effect on hard and soft tissue scaffolds in clinical usage.
Materials and methods: Forty-eight bovine bone matrix and porcine collagen samples were subdivided into two groups (test and control) of 12 samples each. The test group was treated with argon plasma (10 W, 1 bar for 12 minutes), while the control group was left untreated. Immediate cell adhesion and a proliferation assay at 72 hours were performed in the perfusion chamber of a bioreactor. Additionally, micro-CT analysis was performed on the treated and untreated scaffolds, before and after soaking in cell culture medium (four samples).
Results: Osteoblasts seeded on plasma-treated bone matrix significantly increased the adhesion level compared with the untreated sample (43,144.3 ± 12,442.9 vs 21,736 ± 77,27.1; P = .0083). However, 3-day proliferation tests could not achieve significant differences between groups (105,715.5 ± 21,751.5 vs 107,108.6 ± 19,343.4; P = .998). No differences were measured on fibroblast adhesion on the collagen matrix in both conditions. Plasma of argon treatment and soaking in cell culture medium did not affect the bone matrix samples. The structure of collagen matrix samples was unaltered after plasma treatment, but became enlarged after soaking.
Conclusion: Plasma of argon may be useful to biofunctionalize bone grafts, although benefits seemed to disappear after 3 days. No biologic response was detected on collagen matrix scaffolds. In vivo studies are needed to draw final clinical conclusions.
Keywords: biomaterials, bone graft, bone substitute, guided bone regeneration, surface
Purpose: To evaluate the trueness of two intraoral scanners in different clinical situations and considering operator experience.
Materials and methods: Two intraoral scanner systems were used to perform a total of 120 digital impressions of three master casts reproducing three scenarios (single implant, two implants, and four implants [full-arch]). Two operators, one experienced and one unexperienced, were selected.
Results: No differences were found between the two operators. A statistically significant correlation was found with regard to the scanning system used and the clinical scenario analyzed.
Conclusions: Within the limits of this preliminary report, operator experience seems not able to significantly influence the trueness of a digital impression; however, imprecision increased in the full-arch cases for both operators. The twoimplant scenario presented similar trueness values for both scanner systems.
Purpose: Beneficial aspects of short and ultrashort antibiotic administration protocols could be clinically correlated to the reduced side effects on the gastrointestinal microflora. The aim of this Consensus Conference was to establish the necessity of an antibiotic prophylaxis and its dosage to reduce the risk of early implant failure in healthy (ASA 1 or 2), periodontally healthy patients, undergoing basic dental implant surgery (straightforward cases). Additionally, the need for an antiseptic protocol, used before and after the implant surgery, was evaluated.
Materials and Methods: Active members of the Italian Academy of Osseointegration (IAO), together with several worldwide-recognized key opinion experts in the field of microbiology, implant dentistry, and infectious diseases, were participants at this Consensus Conference. Two systematic reviews were carried out, before the Consensus Conference, and their results discussed in order to give guidelines on the administration of an antibiotic/antiseptic prophylaxis in implant surgery. The systematic reviews covered the following topics: (1) the use of antibiotics to reduce both implant failure rate and peri-implant infections in healthy patients and (2) the use of chlorhexidine compositions capable of reducing complications in patients undergoing surgical interventions.
Results: The main statements reached by the assembly were as follows: (1) Rinsing with chlorhexidine is highly recommended before and after implant surgery to minimize the bacterial load. (2) A single dose of antibiotics in straightforward cases is recommended. (3) In complex cases (long surgical time, regeneration procedures), it is advisable to continue the antibiotic administration.
Conclusion: This Consensus Conference advocates the administration of a unique dose of antibiotics in straightforward implant cases combined with the use of chlorhexidine.
Keywords: antibiotics, dental implants, surgery
Purpose: This systematic review aimed to assess the effect of chlorhexidine (CHX) in preventing complications after extractive, implant, and periodontal surgery.
Materials and Methods: The PICO question set for this systematic review was: “Is the use of chlorhexidine formulations able to prevent complications (safety) in patients undergoing procedures of either oral surgery, dental implantology, or periodontology compared to treatment procedures in patients without a chlorhexidine prescription?” Once inclusion and exclusion criteria were established, a search was carried out independently by two researchers on PubMed/MEDLINE, Scopus, and Web of Science. The primary outcomes investigated were the rate of alveolar osteitis and bacteremia after surgical procedures in oral surgery. Meta-analysis and trial sequential analysis (TSA) were performed in order to evaluate the findings.
Results: After the selection, the 32 studies that fully met the eligibility criteria were considered in this systematic review. A meta-analysis was only possible for data obtained from studies related to extractive surgery. Meta-analysis and TSA showed a statistically significant decrease in the rate of alveolar osteitis after tooth extraction when CHX was employed compared with placebo treatments or treatments not using CHX (RR = 0.49; 95% CI: [0.40, 0.60], P < .001; I2 = 8%). Focusing on the rate of bacteremia, meta-analysis and TSA showed how the employment of CHX (RR = 0.87; 95% CI: [0.79, 0.96], P = .004; I2 = 4%) decreases the rate of bacteremia after extractive surgery. Data from the literature seem to lack in the evaluation of CHX use for the reduction of complications in periodontology and implant dentistry.
Conclusion: This systematic review showed with a good power of evidence that CHX employment reduces alveolar osteitis and bacteremia rates after dental extractions.
Keywords: chlorhexidine, complication, efficacy, prevention, systematic review, TSA